academic institutions

Clinical Trial Ethics

Industry Insights from Paul Meade, M. Sc, MPH According to an article published in the Archives of Internal Medicine, Dr Joseph Ross claimed a study conducted by Parke-Davis, before it was acquired by Pfizer, using gabapentin (Neurontin), as the drug under investigation, appeared to be a “seeding” trial. And while the author states that seeding …

Clinical Trial Ethics Read More »

Capitation and Thought Leaders

Industry Insights from Paul Meade, M. Sc, MPH Academic institutions across the United States are placing physicians affiliated with those institutions under an “industry capitation.” What this essentially means is that there are limits to what such physicians can accept from biopharmaceutical companies for services rendered to those companies. In other words, a physician working …

Capitation and Thought Leaders Read More »